ARTICLE | Clinical News
THVD-201: Phase II started
May 23, 2011 7:00 AM UTC
TheraVida began a double-blind, placebo-controlled, crossover, international Phase II trial in 120 female patients to compare 2 mg THVD-201 vs. 2 mg Detrol LA tolterodine tartrate for 16 weeks. Patie...